(TCAF) T. Rowe Price - Ratings and Ratios
Large, U.S., Equities, Technology, Healthcare
Description: TCAF T. Rowe Price
The T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA:TCAF) is an ETF that primarily invests in equity securities, with a focus on large U.S. companies. The funds investment strategy is centered around capitalizing on growth opportunities in various sectors, with a notable emphasis on information technology and healthcare.
From a portfolio composition perspective, the fund is non-diversified, which means it may have a higher concentration of assets in a smaller number of holdings. This could potentially lead to increased volatility, but also presents opportunities for significant gains if the funds investments perform well. Key performance indicators (KPIs) to monitor for this fund include its tracking error relative to its benchmark, sector allocation, and stock selection.
In terms of key metrics, the funds Assets Under Management (AUM) stand at approximately $4.99 billion, indicating a sizable presence in the market. To further evaluate the funds performance, investors may want to examine its expense ratio, Sharpe ratio, and beta relative to its benchmark. Additionally, analyzing the funds holdings turnover and average market capitalization can provide insights into its investment strategy and potential risks.
To assess the funds potential for future growth, investors can examine its relative performance during different market cycles, as well as its ability to adapt to changing market conditions. By evaluating these factors, investors can gain a more comprehensive understanding of the funds strengths and weaknesses, and make more informed investment decisions.
Additional Sources for TCAF ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
TCAF ETF Overview
Market Cap in USD | 4,989m |
Category | Large Blend |
TER | 0.31% |
IPO / Inception | 2023-06-14 |
TCAF ETF Ratings
Growth Rating | 54.5 |
Fundamental | - |
Dividend Rating | 49.0 |
Rel. Strength | -2.24 |
Analysts | - |
Fair Price Momentum | 32.89 USD |
Fair Price DCF | - |
TCAF Dividends
Dividend Yield 12m | 0.42% |
Yield on Cost 5y | 0.57% |
Annual Growth 5y | 42.91% |
Payout Consistency | 100.0% |
Payout Ratio | % |
TCAF Growth Ratios
Growth Correlation 3m | 97.5% |
Growth Correlation 12m | 45.7% |
Growth Correlation 5y | 91.9% |
CAGR 5y | 17.77% |
CAGR/Max DD 5y | 1.09 |
Sharpe Ratio 12m | 1.39 |
Alpha | -1.15 |
Beta | 0.877 |
Volatility | 8.52% |
Current Volume | 863.9k |
Average Volume 20d | 856.2k |
Stop Loss | 34.9 (-2.9%) |
As of August 02, 2025, the stock is trading at USD 35.94 with a total of 863,858 shares traded.
Over the past week, the price has changed by -2.10%, over one month by +1.96%, over three months by +12.07% and over the past year by +13.33%.
Partly, yes. Based on ValueRay´s Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.52 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TCAF is around 32.89 USD . This means that TCAF is currently overvalued and has a potential downside of -8.49%.
T. Rowe Price has no consensus analysts rating.
According to our own proprietary Forecast Model, TCAF T. Rowe Price will be worth about 38.6 in August 2026. The stock is currently trading at 35.94. This means that the stock has a potential upside of +7.35%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.6 | 7.3% |